Besponsa (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Besponsa drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | inotuzumab ozogamicin |
| SUBSTANCE NAME: | INOTUZUMAB OZOGAMICIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-08-18 |
| END MARKETING DATE: | 0000-00-00 |
Besponsa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Besponsa from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.25(mg/mL) |
| START MARKETING DATE: | 2017-08-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0008-0100_ee6c1ea5-47ab-478b-996d-461022339832 |
| PRODUCT NDC: | 0008-0100 |
| APPLICATION NUMBER: | BLA761040 |
Other INOTUZUMAB OZOGAMICIN Pharmaceutical Manufacturers / Labelers:
